Pharmacological evaluation of a phytotherapeutic product - CPV (dry extract of Crataegus oxyacantha L., Passiflora incarnata L. and Valeriana officinalis L.) in laboratory animals

Revista Brasileira de Farmacognosia

Volumn 19, Issue 1 B, 2009, Pages 255-260

  Tabach, Ricardo ^a   Mattei, Rita ^a   Carlini, Elisaldo Luiz De Araujo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiolytic effects; CNS; Crataegus oxyacantha; Passiflora incarnata; Passifloraceae; Rosaceae; Valeriana officinalis; Valerianaceae

Indexed keywords

CRATAEGUS OXYACANTHA EXTRACT; DIAZEPAM; MORPHINE SULFATE; PASSIFLORA INCARNATA EXTRACT; PENTETRAZOLE; PLANT EXTRACT; SCOPOLAMINE; UNCLASSIFIED DRUG; VALERIAN;

AMNESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CRATAEGUS OXYACANTHA; DRUG EFFECT; EXPERIMENTAL ANIMAL; LEARNING; MALE; MAZE TEST; MEDICINAL PLANT; MEMORY; MOUSE; NEUROLEPTANALGESIA; NONHUMAN; PHYTOTHERAPY; PSYCHOPHARMACOLOGY; RAT; TRANQUILIZING ACTIVITY;

EID: 69949104563     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2009000200013     Document Type: Article

References (31)

1. Andreatini R, Sartori VA, Seabra MLV, Leite JR 2002. Effects of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 6: 650-654. (Pubitemid 35334186)
2. Bourin M, Bougerol T, Guitton B, Broutin E 1997.A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fund Clin Pharmacol 11: 127-132. (Pubitemid 27128116)
3. Brandão MGL, Cosenza GP, Moreira RA, Monte-Mor RLM 2006. Medicinal plants and other botanical products from the Brazilian Official Pharmacopoeia. Rev Bras Farmacogn 16: 408-420.
4. Cropley M, Cave Z, Ellis J, Middleton W 2002. Effect of Kava and Valerian on human physiological and psychological responses to mental stress assessed under laboratory conditions. Phytother Res 16: 23-27. (Pubitemid 34116690)
5. Dhawan K, Kumar S, Sharma A 2001. Comparative biological activity study on Passiflora incarnata and P. edulis. Fitoterapia 72: 698-702. (Pubitemid 32799277)
6. Fenner R, Zimmer AR, Neves G, Kliemann M, Gosmann G, Rates SMK 2008. Hypnotic effect of ecdysterone isolated from Pfaffia glomerata (Spreng.) Pedersen. Rev Bras Farmacogn 18: 170-176.
7. Galvão SMP, Marques LC, Oliveira MGM, Carlini EA 2002. Heteropterys aphrodisiaca (extract BST0298): a Brazilian plant that improves memory in aged rats. J Ethnopharmacol 79: 305-311.
8. Galvão SMP, Mendes FR, Oliveira MGM, Mattei R, Carlini EA 2005. Possíveis efeitos adaptógenos da Heteropterys aphrodisiaca O Mach. - Extrato BST0298: uma planta da área do Pantanal Brasileiro. Arq Bras Fitomed Cient 2: 41-55.
9. Gilbert B, Alves LF 2003. Synergy in plant medicines. Curr Med Chem 10: 13-20.
10. Hiller KO, Zetler G 1996. Neuropharmacological studies on ethanol extracts of Valeriana officinalis L.: behavioural and anticonvulsant properties. Phytother Res 10: 145-151. (Pubitemid 26106063)
11. Mattei R, Leite JR, Tufik S 1995. A study of the pharmacological actions of Dioclea grandiflora Mart ex Bent. São Paulo Med J 113: 687-692
12. Mendes FR, Mattei R, Carlini EA 2002. Activity of Hypericum brasiliense and Hypericum cordatum on the central nervous system in rodents. Fitoterapia 73: 462-471. (Pubitemid 35266799)
13. Marliére LDP, Ribeiro AQ, Brandão MGL, Klein CH, Acurcio FA 2008. Utilização de fitoterápicos por idosos: resultados de um inquérito domiciliar em Belo Horizonte (MG), Brasil. Rev Bras Farmacogn 18 (Supl.): 754-760.
14. Morazzoni P, Bombardelli E 1995.Valeriana officinalis: traditional use and recent evaluation of activity. Fitoterapia 66: 99-112.
15. Pellow S, Chopin P, File SE, Briley M 1985. Validation of open closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J Neurosci Meth 14: 149-167. (Pubitemid 16239568)
16. Perazzo FF, Lima LM, Padilha MM, Rocha LN, Pergentino JCS, Carvalho JCT 2008. Anti-inflammatory and analgesic activities of Hypericum brasiliense (Willd) standardized extract. Rev Bras Farmacogn 18: 320-325.
17. Poyares DR, Guilleminault C, Ohayon MM, Tufik S 2002. Can valerian improve the sleep of insomnia after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry 26: 539-545. (Pubitemid 34252948)
18. Quintans-Júnior LJ, Almeida JRGS, Lima JT, Nunes XP, Siqueira JS, Oliveira LEG, Almeida RN, Athayde-Filho PF, Barbosa-Filho JM 2008. Plants with anticonvulsant properties - a review. Rev Bras Farmacogn 18 (Supl.): 798-819.
19. Rigelsky JM, Sweet BV 2002. Hawthorm: pharmacology and therapeutic uses. Am J Health Syst Pharm 59: 417-422.
20. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Ribeiro CF, Macedo T 1994. Synaptosomal GABA release as influenced by valerian root extract involvement of the GABA carrier. Arch Int Pharmacodyn Ther 327: 220-231. (Pubitemid 24224673)
21. Schweizer E, Rickels K 1997. Strategies for treatment of generalized anxiety in the primary care setting. J Clin Psychiatry 58: 27-33. (Pubitemid 27176250)
22. Shanthi R, Parasakthy K, Deepalakshmi PD, Niranjali DS 1996. Protective effect of tincture of Crataegus on oxidative stress in experimental atherosclerosis in rats. J Clin Biochem Nutr 20: 211-223. (Pubitemid 27012418)
23. Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, Mortier F 1997. Behavioral effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J Ethnopharmacol 57: 11-20. (Pubitemid 27303468)
24. Sousa FCF, Melo CTV, Citó MCO, Félix FHC, Vasconcelos SMM, Fonteles MMF, Barbosa-Filho JM, Viana GSB 2008. Plantas medicinais e seus constituintes bioativos: Uma revisão da bioatividade e potenciais benefícios nos distúrbios da ansiedade em modelos animais. Rev Bras Farmacogn 18: 642-654.
25. Speroni E, Billi R, Mercati V, Boncompagni E, Toja E 1996. Sedative effects of crude extract of Passiflora incarnata after oral administration. Phytother Res 10: 92-94. (Pubitemid 27062437)
26. Tabach R, Rodrigues E, Carlini EA 2008. Preclinical toxicological assessment of a phytotherapeutic product - CPV (based on dry extracts of Crataegus oxyacantha L., Passiflora incarnata L., and Valeriana officinalis L.). Phytother Res 23: 33-40.
27. Valle NB, Leite JR 1983. Efeitos psicofarmacológicos de preparações de Passiflora edulis (maracujá). Cienc Cult 35: 11-24.
28. Valli M, Paubert-Braquet M, Picot S, Fabre R, Lefrançois G, Rod D 1991. Euphytose® an association of plant extracts with anxiolytic activity: investigation of its mechanisms of action by an in vitro binding study. Phytother Res 5: 241-244.
29. Williamson EM 2001. Synergy and other interactions in phytomedicines. Phytomedicine 8: 401-409.
30. Yuan R, Lin Y 2000. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther 86: 191-198. (Pubitemid 30229901)
31. Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK 2004. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 98: 353-358. (Pubitemid 38129379)